It has been proven that this miniature version of Agrin could be increased expression in muscles by direct intramuscular injection and render remarkable therapeutic benefits in a mouse model of congenital muscular dystrophy [28, 34]. Here, AGRN is linked to congenital muscular dystrophy due to LMNA mutation.